According to Cue Biopharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.20. At the end of 2024 the company had a P/S ratio of 3.47.
Year | P/S ratio | Change |
---|---|---|
2024 | 3.47 | -84.02% |
2023 | 21.7 | -77.97% |
2022 | 98.5 | 304.14% |
2021 | 24.4 | -79.75% |
2020 | 120 | -1.28% |
2019 | 122 | 19.28% |
2018 | 102 |